NO20055254L - Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte - Google Patents

Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte

Info

Publication number
NO20055254L
NO20055254L NO20055254A NO20055254A NO20055254L NO 20055254 L NO20055254 L NO 20055254L NO 20055254 A NO20055254 A NO 20055254A NO 20055254 A NO20055254 A NO 20055254A NO 20055254 L NO20055254 L NO 20055254L
Authority
NO
Norway
Prior art keywords
spasticity
treatment
pain
pharmaceutical combination
weight
Prior art date
Application number
NO20055254A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055254D0 (no
Inventor
Istvan Tarnawa
Karoly Tihanyi
Pal Kocsis
Balazs Dalmadi
Gyorgy Nemeth
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20055254D0 publication Critical patent/NO20055254D0/no
Publication of NO20055254L publication Critical patent/NO20055254L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20055254A 2003-04-09 2005-11-08 Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte NO20055254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0300929A HUP0300929A3 (en) 2003-04-09 2003-04-09 Analgetic and/or muscle relaxant pharmaceutical composition
PCT/HU2004/000032 WO2004089352A2 (en) 2003-04-09 2004-04-07 Pharmaceutical combination for the treatment of spasticity and/or pain

Publications (2)

Publication Number Publication Date
NO20055254D0 NO20055254D0 (no) 2005-11-08
NO20055254L true NO20055254L (no) 2006-01-06

Family

ID=90001682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055254A NO20055254L (no) 2003-04-09 2005-11-08 Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte

Country Status (16)

Country Link
US (1) US20060199841A1 (ru)
EP (1) EP1610785B1 (ru)
JP (1) JP2006522786A (ru)
AT (1) ATE370733T1 (ru)
CY (1) CY1106903T1 (ru)
DE (1) DE602004008440T2 (ru)
DK (1) DK1610785T3 (ru)
EA (1) EA007732B1 (ru)
ES (1) ES2293245T3 (ru)
HR (1) HRP20070441T3 (ru)
HU (1) HUP0300929A3 (ru)
NO (1) NO20055254L (ru)
PL (1) PL1610785T3 (ru)
PT (1) PT1610785E (ru)
RS (1) RS20050738A (ru)
WO (1) WO2004089352A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143671D1 (de) * 2001-06-07 2011-01-27 Sang Christine Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists
US8262942B2 (en) 2008-02-07 2012-09-11 The George Washington University Hollow carbon nanosphere based secondary cell electrodes
TR201720289A2 (tr) * 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları
JP7169580B2 (ja) * 2018-09-27 2022-11-11 株式会社Ｌｔｔバイオファーマ 線維症治療用医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
AU2929489A (en) * 1987-12-22 1989-07-19 John W. FERKANY Dextrorphan potentiator for anticonvulsant composition and method
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
JP4097285B2 (ja) * 1994-09-22 2008-06-11 リチャード・アラン・スミス 種々の頑固な疾患の治療のための医薬の製造に有用な組成物
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
CA2264182A1 (en) * 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
WO2004089352A2 (en) 2004-10-21
DE602004008440T2 (de) 2008-05-21
DE602004008440D1 (de) 2007-10-04
DK1610785T3 (da) 2007-10-22
NO20055254D0 (no) 2005-11-08
EA200501591A1 (ru) 2006-06-30
EP1610785B1 (en) 2007-08-22
RS20050738A (sr) 2008-04-04
ATE370733T1 (de) 2007-09-15
US20060199841A1 (en) 2006-09-07
PL1610785T3 (pl) 2008-01-31
PT1610785E (pt) 2007-09-10
HUP0300929A2 (hu) 2005-02-28
JP2006522786A (ja) 2006-10-05
EA007732B1 (ru) 2006-12-29
EP1610785A2 (en) 2006-01-04
HRP20070441T3 (hr) 2007-10-31
HUP0300929A3 (en) 2005-06-28
CY1106903T1 (el) 2012-09-26
WO2004089352A3 (en) 2004-12-16
ES2293245T3 (es) 2008-03-16
HUP0300929D0 (en) 2003-06-28

Similar Documents

Publication Publication Date Title
GB0022438D0 (en) Organic Compounds
TW200615266A (en) Organic compounds
NO20073719L (no) Kjemiske forbindelser
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA04012965A (es) Inhibidores virales.
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20040881L (no) Orale antidiabetes midler.
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
EP1541660A4 (en) RADICAL REACTION INHIBITORS, INHIBITION OF RADICAL REACTIONS AND THEIR USE
WO2003101382A3 (en) Compounds useful in the treatment of anthrax and inhibiting lethal factor
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
NO20055254L (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte
NO20060718L (no) Substituerte tiofoner og deres anvendelse
PL1970372T3 (pl) Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami
GB0012795D0 (en) Organic compounds
MY136965A (en) 1,4-disubstituted piperidine compounds, their preparation and use as medicaments
NO20063790L (no) Substituerte azetidin sammensetninger som cyclooxygenase-1-cyclooxygenase-2-inhibitorer, og deres fremstilling og anvendelse som medikamenter
NO20062307L (no) Spirofuropyridinarylderivater
MXPA05008190A (es) Derivado de oligosacarido.
BRPI0406580A (pt) Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase
EP1940385A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A RUTHENIUM OXALATO COMPOUND AND METHOD OF UTILIZING THEREOF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application